Yesterday, U.S. Trade Representative Gril said to the media: "The U.S. and Switzerland have reached a trade framework agreement. The tariffs on Swiss imports into the U.S. will be reduced from 39% to 15%, matching the EU's treatment. These tariffs may take effect within a few weeks. In exchange, Switzerland has pledged to invest $200 billion in the U.S. by 2028, with $67 billion to be in place by 2026, covering areas such as pharmaceuticals and medical devices, including previous investment commitments from companies like Roche and Novartis. The agreement will affect 40% of Switzerland's exports. This will help reduce the U.S. trade deficit and create a large number of jobs. Both sides aim to finalize the agreement in the first quarter of 2026. Switzerland is indeed the roof of Europe; its world-famous precise and efficient national governance and top industry strength are impressive!"
[Cunning] What Gril referred to as precise and efficient is nothing more than Switzerland's reluctant payment under the threat of a 39% tariff. This seemingly equal benefit exchange is actually a compromise by a small country to a hegemon - Switzerland exchanges $200 billion in investments for market breathing space, essentially a passive concession after being held hostage by U.S. export arteries. The so-called parity with the EU treatment is more like a hegemonic rule tailored by the U.S. - you make concessions, and I will give you equal treatment. Switzerland's top industrial strength ultimately becomes a pawn to hedge against tariff risks. Beneath the halo of permanent neutrality lies the reality of being coerced to shift supply chains! A comment stated that this deal tore off the facade of supposed rule fairness, exposing the naked interest exchange, which is another model of U.S. tariff pressure plus investment harvesting. It makes America's "greatest" appear bloody!
Original: www.toutiao.com/article/1848812401459460/
Statement: The article represents the views of the author.